Ching Chan Optical Technology Co., Ltd. logo

Ching Chan Optical Technology Co., Ltd. (2070)

Market Closed
12 Jun, 05:30
TWSE TWSE
NT$
62. 60
-0.6
-0.9494%
NT$
- Market Cap
- P/E Ratio
2.4% Div Yield
308,000 Volume
- Eps
NT$ 63.2
Previous Close
Add Transaction
Day Range
62.6 65.4
Year Range
36.35 82.9
Want to track 2070 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

2070 closed today lower at NT$62.6, a decrease of -0.9494% from yesterday's close, completing a monthly decrease of -19.3299% or -NT$15. Over the past 12 months, 2070 stock gained 49.7608%.
2070 pays dividends to its shareholders, with the most recent payment made on May 08, 2026. The next estimated payment will be in In 4 months on Nov 08, 2026 for a total of NT$1.
The last earnings report, released on Aug 11, 2025, exceeded the consensus estimates by 0.2734%. On average, the company has surpassed earnings expectations by 0.0911%, based on the last three reports.
Ching Chan Optical Technology Co., Ltd. has completed 2 stock splits, with the recent split occurring on Aug 29, 2017.
The company's stock is traded on 2 different exchanges and in various currencies, with the primary listing on XSAU (SAR).

2070 Chart

Ching Chan Optical Technology Co., Ltd. (2070) FAQ

What is the stock price today?

The current price is NT$62.60.

On which exchange is it traded?

Ching Chan Optical Technology Co., Ltd. is listed on TWSE.

What is its stock symbol?

The ticker symbol is 2070.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 2.4%.

What is its market cap?

As of today, no market cap data is available.

Has Ching Chan Optical Technology Co., Ltd. ever had a stock split?

Ching Chan Optical Technology Co., Ltd. had 2 splits and the recent split was on Aug 29, 2017.

Ching Chan Optical Technology Co., Ltd. Profile

Specialty Retail Industry
Consumer Discretionary Sector
- CEO
TWSE Exchange
TW0002070000 ISIN
Saudi Arabia Country
- Employees
10 Jun 2026 Last Dividend
27 Dec 2009 Last Split
- IPO Date

Overview

The Saudi Pharmaceutical Industries and Medical Appliances Corporation is a stalwart in the realm of healthcare and pharmaceuticals within the Kingdom of Saudi Arabia. Since its inception in 1986, the company has firmly established itself by developing, manufacturing, and distributing a wide range of medicinal and pharmaceutical products. Headquartered in Buraydah, it has expanded its footprint to encompass the manufacturing of basic chemical substances, medical and cosmetic products, alongside wholesaling and retailing medicines and related products. The company is not only dedicated to commercial activities but also prioritizes the advancement of medical science through its robust research and development framework. Additionally, it contributes to the healthcare system by operating and maintaining healthcare facilities, manifesting its comprehensive involvement in enhancing health and wellness across the nation.

Products and Services

  • Medicinal and Pharmaceutical Products: The mainstay of the corporation, these products are developed, manufactured, and marketed with the intent to meet the diverse healthcare needs within the Kingdom. This includes a broad spectrum of medications intended for various therapeutic applications.
  • Basic Chemical Substances and Products: Beyond pharmaceuticals, the company takes significance in producing basic chemical substances. This facet of their operation underscores their role in the wider chemical industry, providing foundational materials necessary for a variety of applications.
  • Medicines for Human Use, Including Cosmetics: Their product lineup is not limited to medicinal drugs but also extends to cosmeceuticals. This demonstrates their holistic approach to wellbeing, acknowledging the intersection between healthcare and personal care.
  • Wholesale and Retail of Medicines and Related Products: The company ensures the accessibility of its products through a well-established chain of wholesale and retail distribution. This network facilitates the delivery of medicines and related products to a wide audience, including healthcare institutions and the general public.
  • Operation and Maintenance of Healthcare Facilities: In its commitment to contribute to the healthcare ecosystem, the corporation ventures into the operation and maintenance of healthcare facilities. This aspect of their service underscores a direct investment in the quality of patient care and healthcare infrastructure.
  • Research and Development in Medical Science Activities: Innovation is at the heart of the company's ethos, with active engagement in research and development. These activities not only foster the evolution of existing products but also pave the way for groundbreaking medical solutions, signaling the company's dedication to scientific advancement and therapeutic innovation.

Contact Information

Address: King Abdul Aziz Road
Phone: -